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Effects of dodecacalcium hepta-
aluminate content on the setting time, 
compressive strength, alkalinity, and 
cytocompatibility of tricalcium silicate 
cement
Objective: This study aimed to investigate the effects of dodecacalcium 
hepta-aluminate (C12A7) content on some physicochemical properties 
and cytocompatibility of tricalcium silicate (C3S) cement using human 
dental pulp cells (hDPCs). Material and Methods: High purity C3S cement 
was manufactured by a solid phase method. C12A7 was mixed with the 
cement in proportions of 0, 5, 8, and 10 wt% (C12A7-0, -5, -8, and -10, 
respectively). Physicochemical properties including initial setting time, 
compressive strength, and alkalinity were evaluated. Cytocompatibility was 
assessed with cell viability tests and cell number counts. Statistical analysis 
was performed by using one-way analysis of variance (ANOVA) and Tukey’s 
test (p<0.05). Results: The initial setting time of C3S-based cement was 
shorter in the presence of C12A7 (p<0.05). After 1 day, C12A7-5 showed 
significantly higher compressive strength than the other groups (p<0.05). 
After 7 days, the compressive strength of C12A7-5 was similar to that of 
C12A7-0, whereas other groups showed strength lower than C12A7-0. The 
pH values of all tested groups showed no significant differences after 1 day 
(p>0.05). The C12A7-5 group showed similar cell viability to the C12A7-0 
group (p>0.05), while the other experimental groups showed lower values 
compared to C12A7-0 group (p<0.05). The number of cells grown on the 
C12A7-5 specimen was higher than that on C12A7-8 and -10 (p<0.05). 
Conclusions: The addition of C12A7 to C3S cement at a proportion of 5% 
resulted in rapid initial setting time and higher compressive strength with 
no adverse effects on cytocompatibility.
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Introduction
Since its introduction in the 1990s, mineral 
trioxide aggregate (MTA) has been widely used in the 
endodontic field for purposes including retrograde 
filling, perforation repair, apexification, and vital pulp 
therapy.1 Considerable evidence has demonstrated the 
excellent biocompatibility and sealing ability of MTA 
and promising outcomes for endodontic procedures.2,3 
Nevertheless, because of drawbacks including long 
setting time and initial wash-out possibility, poor 
handling characteristics, discoloration of teeth, and 
heavy metal content, the development of novel MTA-
like calcium silicate (CS) cement to overcome these 
drawbacks and improve biocompatibility and clinical 
convenience of MTA is an important goal.4
The composition of MTA is similar to that of Portland 
cement except for the presence of radiopacifier-
like bismuth oxide, which is generally composed 
of tricalcium silicate (C3S), dicalcium silicate 
(C2S), tricalcium aluminates (C3A), tetracalcium 
aluminoferrite, and other ingredients.5 Among these, 
C3S is one of the major constituents of MTA.6 C3S 
forms into calcium silicate hydrates (C-S-H) through 
hydration reactions with water, which contribute to 
the spontaneous development of strength.7 Despite 
its excellent in vitro bioactivity and biocompatibility,8 
C3S alone has limitations in clinical contexts due to its 
long setting time and low mechanical strength during 
the early stages of hydration.9
Tricalcium aluminate (C3A) is the most reactive 
part of Portland cement.10 When C3A is mixed with 
calcium silicate, it contributes to the initial hydration 
process of the cement.10 In studies, C3A mixed with 
calcium silicate cement showed a faster hydration rate 
and higher initial mechanical strength than non-mixed 
cement.7,9,10 Dodecacalcium hepta-aluminate (C12A7), 
one of the stable phases of calcium aluminates (CA), 
is also expected to react rapidly with water and may 
provide beneficial properties during the early hydration 
stages of calcium silicate. However, there have been 
no attempts to mix C12A7 in C3S cement and evaluate 
the effects of C12A7 on cement in dental contexts. This 
study aimed to evaluate the effects of C12A7 on C3S 
cement regarding some physicochemical properties 
and cytocompatibility with hDPCs. We manufactured 
high-purity cement with uniformly fine particles 
to determine the optimal component ratio of C3S/
C12A7 for use as an endodontic biomaterial. The null 
hypothesis was that cements with different C12A7 




For the manufacture of C3S cement powder, 
calcium carbonate (Sigma-Aldrich, St. Louis, MO, USA) 
and silicon dioxide (Junsei Chemical, Kyoto, Japan) 
were uniformly mixed in a 3:1 molar ratio and stirred 
by ball milling for 1 h in ethanol. The powder (10 g) 
was put into a mold 15-mm in diameter and pressed 
uniaxially at pressures of 2 to 3 t. After the cylinder-
type pelletized samples were desiccated at 40°C for 
12 h, the sample was heated at a rate of 10°C/min 
to the sintering temperature of 1400-1500°C, held 
for 1 to 20 h, and then cooled. Sintering process was 
repeated four times to achieve higher proportions of 
C3S in the cement. The sintered material was ground 
to powders less than 8 μm in diameter by using air 
jet mill (CGS16, NETZSCH GmbH, Selb, Germany) 
with 6000 rpm. The characteristics of prepared C3S 
cement powder were evaluated with X-ray diffraction 
(XRD) analysis (D/MAX 2500V/PC, Rigaku, Tokyo, 
Japan), a laser diffraction particle size analyzer (LS 
13 320, Beckman Coulter Inc., Miami, FL, USA), 
and a scanning electron microscope (SEM; S-4300, 
Hitachi, Tokyo, Japan). C12A7 was manufactured as 
follows; calcium oxide (Sigma-Aldrich) and aluminum 
hydroxide (Duksan pure chemical, Ansan, Korea) were 
uniformly mixed at a 12:7 molar ratio. The mixed 
compounds were heated at 1100°C and quenched 
to fabricate a hydratable mixture of CA. Then CaO-
Al2O3-H2O was obtained by adding water to the 
calcium aluminates, and the hydrates were heated at 
1100°C and quenched, resulting in CaO-Al2O3 clinker, 
which was ground to powder. To prepare the C3S/
C12A7 mixture, the resultant C3S powder was mixed 
with C12A7 powder at proportions of 0, 5, 8, and 10 
wt% of C12A7 (noted as C12A7-0, -5, -8, and -10, 
respectively).
Initial setting time
We measured the initial setting time according to 
the recommendations specified in ISO 6876:2012. 
Each of the four powder groups was mixed with 
distilled water (DW) at a liquid-to-powder ratio of 0.4 
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mL/g and then inserted into Teflon molds of 1-mm 
thickness and 10-mm diameter. The initial setting time 
of the specimen (n=3) was measured using a Gilmore 
apparatus at 30-s intervals. Then, a 1/4-pound 
stainless steel indenter was applied vertically on to the 
horizontal surface of the specimen for 5 s. The initial 
setting time was determined as the time at which the 
indenter ceased to leave a distinct indentation on the 
surface of the specimen.
Compressive strength test
Compressive strength was determined according 
to ISO 9917-1:2003. After the powder was mixed 
with DW, the resulting cement was inserted into 
Teflon molds of 6-mm thickness and 4-mm diameter 
and allowed to set at 37°C (n=10). After 1 or 7 
days, compressive strength was measured using a 
universal testing machine (Z020, Zwick GmbH, Ulm, 
Germany) with a 0.5-N load cell at a crosshead speed 
of 1.0 mm/min. We calculated compressive strength 
with following formula: C=4P/D2, where C is the 
compressive strength (MPa), P is the maximum load 
force before fracture (N), and D is the diameter (mm) 
of the specimen.
Alkalinity
Alkalinity was evaluated by measuring pH according 
to a previously published study.11 In brief, we prepared 
specimen (1-mm thickness and 5-mm diameter) and 
allowed to set completely. After setting, we inserted 
one tablet into 10 mL of deionized water. Then, the pH 
value was measured using a pH meter (Orion 3 Star; 
Thermo Fisher Scientific, Singapore).
Primary culture of human dental pulp cells 
(hDPCs)
The experimental procedures with hDPCs of this 
study were approved by the institutional review 
board (IRB No: 2018-02-013). From the sectioned 
teeth, dental pulp tissue was obtained aseptically and 
rinsed with phosphate buffered saline (PBS; HyClone 
Laboratories Inc., Logan, UT, USA). The tissue was 
minced into small fragments in a 60-mm dish (Nunc, 
Roskilde, Denmark) and cultured in Minimum Essential 
Medium-α (MEM-α; HyClone Laboratories Inc.) 
containing 10% fetal bovine serum (FBS; Invitrogen, 
Carlsbad, CA, USA), 100 U/mL penicillin and 100 U/
mL streptomycin (Invitrogen) at 37°C in 5% CO2. The 
cells between the third and fifth passages were used 
in this study.
Cell viability test
After the powder was mixed with DW, the cement 
was allowed to set in disc shaped-paraffin wax molds 
(2 mm × 10 mm) for 24 h at 37°C. The cement was 
sterilized under ultraviolet light for 1 h. Then, the 
specimen was immersed in MEM-α containing 10% 
FBS at a ratio of 0.5 cm2/mL for 3 days to prepare 
the material extracts. The cells (2 × 104/well) were 
inoculated in 24-well culture plates and incubated in 
culture medium. After 24 h, the cells were treated 
with 1 mL of the prepared extracts (n=4). The sample 
which contained no material extract was used as 
negative control, and C12A7-0 was considered as 
positive control. After 24 or 48 h, cell viability was 
measured by using the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
Briefly, MTT solution (0.05%, 0.2 mL) was added 
to each well, and the cells were incubated for 2 h. 
Then, 0.2 mL of dimethyl sulfoxide (Amresco, Solon, 
OH, USA) was inserted to each well. After the plates 
were shaken for about 5 min, the optical density was 
measured spectrophotometrically at 590 nm by using 
a microplate reader (SPECTROstarNano, BMG Labtech, 
Ortenberg, Germany).
Measurements of the numbers of hDPCs
Each powder sample for each of four groups was 
mixed with DW at a liquid-to-powder ratio of 0.4 mL/g 
and allowed to set in a disc shaped-paraffin wax mold 
(1 mm × 5 mm) for 24 h at 37°C. Cells (1 × 105) were 
inoculated on each specimen in the 24-well plates and 
cultured for 48 h in culture media (n=3). Then, the 
cells were stained with 4’,6-diamidino-2-phenylindole 
(DAPI) (Invitrogen) and scanned by a confocal laser 
scanning microscope (LSM 510 META, Carl Zeiss, Jena, 
Germany). Cell numbers were analyzed quantitatively 
from acquired images with an image analysis program 
(Image J ver. 1.37; National Institutes of Health, 
Bethesda, MD, USA).
Statistical analysis
The results were statistically analyzed using one-
way analysis of variance (ANOVA) and Tukey’s tests 
to detect any significance (p<0.05). Prior to the 
analysis, the Kolmogorov-Smirnov test was used for 
determining normal distribution. The analyses were 
performed using SPSS software (SPSS ver. 12.0; SPSS 
Inc., Chicago, IL, USA).
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Results
Characterization of C3S and C12A7
The characteristics of prepared C3S and C12A7 
were identified by SEM and XRD (Figure 1). The 
SEM images of fabricated C3S powders showed 
homogeneous composition of particles (Figure 1A and 
1B). Phase analysis results by XRD indicated that the 
prepared powders were C3S and C12A7, respectively 
(Figure 1C and 1F). Quantitatively, the proportion of 
C3S was 100%, and particle size was less than 8 μm 
(Table 1).
Figure 1- Characterization of prepared C3S and C12A7 powder; (A-B) Scanning electron microscope (SEM) images (x1000 and x3000, 
respectively) showed homogeneous compositions of particles in the C3S cement; (C) X-ray diffraction (XRD) characteristics of fabricated 
cement confirmed the powder as the C3S showing precisely identical peaks with that; (D-E) SEM images (x3000 and x10000, respectively) 
showed the characterization of the surface of C12A7 powder. (f) Fabricated powder was confirmed as C12A7 showing the same XRD 
peaks
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Measurement of initial setting time, compressive 
strength, and alkalinity
Initial setting time and compressive strength 
were measured to determine the physicochemical 
properties of cement with different ratios of C12A7. 
Regarding the initial setting time, there were 
significant differences between control (C12A7-0) 
and other samples (C12A7-5, -8, and -10) (p<0.05) 
(Figure 2A). As shown in Figure 2B, the compressive 
strength of C12A7-5 was significantly higher than 
that of other groups 1 day after the setting (p<0.05). 
However, there was no statistical difference between 
the other groups (p>0.05). After 7 days, the strength 
of C12A7-5 was similar to C12A7-0, whereas other 
groups showed lower strength compared to C12A7-0 
(Figure 2B) (p>0.05). Regarding alkalinity, samples of 
all groups showed high pH values around 10 - 12 with 
an increasing pattern for 7 days. Although pH values 
of C12A7-0 were higher than other groups within 6 h 
(p<0.05), there were no significant differences after 
1 day (Figure 2C). Furthermore, the C12A7-5 group 
showed higher pH value than C12A7-8 and -10 within 
6 h (p<0.05).
Measurement of viability and the number of 
hDPCs
Viability and number of hDPCs were measured 
to investigate the cytocompatibiltiy of the cement. 
Although the cell viability of C12A7-containing cement 
decreased as the proportion of C12A7 increased, the 
cell viability of C12A7-5 was similar to that of both 
negative and positive control (C12A7-0) (p>0.05). 
Significantly lower cell viability than the control 
group in C12A7-10 was observed after 1 day and in 
C12A7-8 and -10 after 2 days (Figure 3A). Differences 

















Table 1- Characteristics of prepared cement powder. "d<n" is 
defined as the diameter at which n% of the sample's cumulative 
mass is comprised of particles with a diameter less than this 
value in the particle size distribution, and "dmax" is defined as 
the maximum diameter of particle size
Figure 2- The physicochemical properties of C3S cement containing the various proportion of C12A7; (A) Initial setting time, (B) 
compressive strength, and (C) pH. statistical significance was determined at p<0.05
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samples with various proportions of C12A7. While the 
cell numbers of C12A7-containing groups showed no 
statistical differences compared to the C12A7-0 group, 
the cell numbers of C12A7-5 were higher than those 
of C12A7-8 and -10 (p<0.05) (Figure 3B-F).
Discussion
Portland cement acquired from natural materials 
can vary in composition and include impurities such 
as heavy metals of leachable lead and arsenic.1 
According to several studies, commercially available 
MTAs may also contain heavy metals, although the 
amount released by MTAs is less than that of Portland 
cement.12 This contamination is of major concern in 
the development of cements that have high-purity CS, 
which leads to compositional stability and reliability, 
and the exclusion of heavy metal elements.13 Most new 
formulations of CS-based cements are currently based 
on C3S.14 C3S-based cement can be manufactured 
using pure raw materials, unlike Portland cement. C3S-
based cement exhibits adequate physical properties 
and biologic performances, showing microstructure 
and hydration characteristics similar to those of 
Portland cement.15 In this study, we fabricated pure 
C3S cement with fine particles in the laboratory to 
exclude impurities and produce a stable composition 
of the base material (Figure 1A-C and Table 1). The 
processes of sintering, cooling and grinding were 
repeated to enhance the reaction rate of CaO-SiO2 by 
solid-state reaction, bringing about high proportions 
of C3S. The highly purified C3S cement we produced 
is expected to provide non-biased and stable results 
when used as a base material for evaluation of other 
additives in terms of effects on the base material.
Although C3S is largely responsible for initial setting 
and early strength of concrete used in the building 
industry, cement must have even more rapid setting 
ability for clinical applications. Several authors have 
Figure 3- The cytocompatibility of C3S cement with the various proportions of C12A7; (A) The effects of C3S cement containing the 
various proportions of C12A7 on cell viability measured by the MTT assay; (B) The effects of C3S cement with the various proportions 
of C12A7 on the proliferation of hDPCs cultured on the specimens; (C-F) Representative confocal laser scanning microscopic images 
(x200) showing hDPCs (stained with DAPI) growing on the specimens (C12A7-0, 5, 8, and 10, respectively) after 48 h of culture. Statistical 
significance was determined at p<0.05
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shown that the addition of CA induces faster hydration 
reactions and improvements of the early mechanical 
strength of CS-based cement.7,10 C3A has been used 
as a representative additive in CS-based cement. 
However, the synthesis of non-blended C3A clinker 
is an energy-consuming process, because sintering 
must be repeated several times to avoid eutectic and 
peritectic reactions on the CaO-Al2O3 phase diagram. In 
contrast, C12A7 is more efficient to fabricate than C3A, 
due to its favorable sinterability. In addition, C12A7, 
known as mayenite, is one of the intermediary phases 
of the CaO-Al2O3 binary system and is also known to 
contribute to the first stage of strength development 
in aluminous cements like C3A.16 Therefore, C12A7 
was selected for use in this study and was fabricated 
by sintering processes (Figure 1D-F).
Despite characteristics related to initial rapid 
hydration, high concentrations of CA can result in 
low final mechanical strength and negative effects 
on biocompatibility.7 Hence, we prepared various 
proportions of C12A7/C3S cement by mixing C12A7 
with C3S cement to investigate the best proportions 
of C12A7 in C3S cement. In clinical contexts, MTA is 
surrounded by vital tissues like pulp and periodontal 
ligaments, as well as tissue fluids and blood. Faster 
initial setting and greater early strength can provide 
better initial support in bioactive circumstances. 
According to the previous report, the initial setting 
time of Portland cement was around 25 min,17 which 
is similar to our results of pure C3S (C12A7-0) around 
23 min. On the other hand, commercially available 
products showed shortened initial setting time 
around 10-15 min.17-19 In C12A7-containing groups 
(C12A7-5, 8 and 10) of this study, the setting time 
was significantly shortened compared to pure the C3S 
group (C12A7-0), resulting in a value less than 15 min 
similar to that of commercial products (Figure 2A).17-19 
In this respect, the addition of C12A7 in C3S cement 
showed significant benefit regarding the reduction 
of initial setting time. Furthermore, according to the 
results of the compressive strength test after 1 day, 
C12A7-5 showed higher early strength compared to 
C12A7-0. The compressive strength values obtained 
in this study were higher than those of MTA in another 
previous study.20 The results indicated that the addition 
of C12A7 might be beneficial for the early strength 
of the cement. Although the values of C12A7-8 and 
-10 decreased compared to control after 7 days, 
C12A7-5 showed no significant difference compared 
to the control group (Figure 2B). We also evaluated 
the pH of hydrated samples, since alkalinity is one 
of the most important characteristics of CS-based 
cement, as it is related to antimicrobial effect and 
dentin bridge formation near the pulp cells.1,20,21 The 
pH values increased during the period until 7 days, 
retaining high alkalinity at around 10 - 12, showing 
similar pattern and values with other previous studies 
using white MTA.18,21 Although the alkalinity of C12A7-0 
was significantly higher in the early period within 6 h, 
there were no differences among all groups after 24 h 
(Figure 2C). Based on these findings from the initial 
setting time, compressive strength, and alkalinity 
test, we suggest that the addition of 5% C12A7 to 
C3S cement provide suitable benefit in terms of the 
clinical perspectives.
To evaluate the effect of C12A7 on the 
cytocompatibility of C3S-based cement in our study, we 
performed cell viability tests and measurements of cell 
number with hDPCs. Previously, several cell lines,3,8,10 
were used for cell viability tests of CS-based cement. 
However, susceptibility to toxicity may vary between 
human- and animal-derived cells. Moreover, in clinics, 
as CS-based cement usually contacts exposed dental 
pulp when used as direct pulp capping materials, using 
the hDPCs can provide more exact informations.22 
In our study, although cell viability decreased with 
increasing C12A7 concentration, the cell viability of 
C12A7-5 was similar to that of the control group after 
1 and 2 days (p>0.05) (Figure 3A). Furthermore, the 
C12A7-5 group showed higher cell count than other 
groups (Figure 3B). In general, CS-based cement 
has proven to be biocompatible and to stimulate cell 
proliferation.23 It has been also reported that the 
dissolution of calcium and silicate ions from CS-based 
cements stimulates cell proliferation.8,24 However, the 
addition of CA can also exhibit negative effects on 
cytocompatibility in measures such as cell viability, 
attachment, and growth.7 It was also reported that, 
within the range of 10% of C3A in C3S, there was non-
cytotoxic in the L929 cell.10 According to our results, 
we argue that adding 5% C12A7 to C3S cement does 
not negatively affect the cytocompatibility of hDPCs.
Conclusions
In our study, we fabricated purified C3S cement 
and evaluated the effects of C12A7 when added to 
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C3S cement, in order to identify a suitable proportion 
of this combination used in clinical contexts. 
Within the limitations of this study, we found that 
C3S-based cement with 5% C12A7 exhibited 
optimal characteristics, including faster initial setting 
time, improved compressive strength, and optimal 
alkalinity without adverse effects on cytocompatibility. 
Therefore, C3S-based cement containing 5% C12A7 
could be used as a base material for the further study 
and development of new biomaterials for endodontic 
procedures.
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